Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
3 CALLS ON FILE
NAGE
— Niagen Bioscience Inc
NASDAQ
FULL STOCK PAGE →
Q1 2026 Earnings Call Summary
MAY 6, 2026
REVENUE
$31.5M
-7.0%
NET MARGIN
20.1%
+7.9 PTS
EPS
$0.08
+51.2%
FREE CASH FLOW
-$1.3M
-317.1%
No summary has been written for this call yet.
← NEWER CALL
CALL 1 OF 3
OLDER CALL →